Moderna’s spending cuts, pipeline shakeup leave doubts about a …

Moderna’s cost-reduction plans, pipeline cuts and reined-in financial guidance, unveiled Thursday, triggered a wave of downgrades as analysts focused on longer timelines to launch some …

CouponFollow Extension

18%
OFF

Moderna's Stock Slides As It Slashes Research Spending, Trims Pipeline

3 weeks from now

Sep 12, 2024 · Moderna Inc.'s stock fell more than 18% Thursday after the company said it will rein in its research-and-development spending and trim its pipeline as it looks to shake off the …

morningstar.com

$1
OFF

Moderna Targets $1.1B In R&D Spending Cuts, Drops 5 Programs …

3 weeks from now

Sep 12, 2024 · Cutting the budget will take time, with Moderna forecasting R&D spending of $4.2 billion to $4.5 billion in 2025. The biotech disclosed a raft of pipeline changes as part of the …

fiercebiotech.com

$1
OFF

Moderna R&D Day: $1 Billion In Cost Cuts, 10 Product Launches

3 weeks from now

Sep 12, 2024 · Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

cnbc.com

20%
OFF

Moderna To Cut Costs, Trim Pipeline In R&D Revamp

3 weeks from now

Sep 12, 2024 · Dive Brief: Moderna will cut R&D spending by 20% and trim its pipeline as part of a strategic overhaul that will shift its research focus and put more resources into products that …

biopharmadive.com

$1
OFF

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

3 weeks from now

5 days ago · Moderna says it will cut $1.1bn off its annual ... Moderna is showcasing its R&D pipeline to investors today, but the headline news is a decision to cut its R&D spend by a …

pharmaphorum.com

20%
OFF

StockWatch: Moderna's $1.1B R&D Cut, Profitability Delay Jolt …

3 weeks from now

Sep 16, 2024 · Over the next three years, Moderna added, it will cut about between $1 billion and $1.2 billion in expenses by shrinking its R&D budget by about 20%, going from the $4.8 billion …

genengnews.com

$1
OFF

Moderna Plunges As Sales View Disappoints, Research Budget Cut

3 weeks from now

Sep 12, 2024 · The biotech is discontinuing five programs in its pipeline and slowing some late-stage studies of treatments for latent and rare diseases to achieve the $1.1 billion cut from its …

bnnbloomberg.ca

$4
OFF

Facing ‘Daunting’ Launch Schedule, Moderna To Slash $4B

3 weeks from now

Sep 13, 2024 · Analysts expressed skepticism about plans detailed by Moderna’s R&D chief Stephen Hoge to trim research spending in preparation for the launch of up to 10 new …

biospace.com

$1
OFF

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

3 weeks from now

Sep 13, 2024 · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

25%
OFF

Moderna Stock Plunges As Vaccine Maker Slashes R&D Budget

3 weeks from now

Sep 12, 2024 · In the release, Moderna also said it anticipates fiscal 2025 revenue to be in the range of $2.5 billion to $3.5 billion and sales to grow at a 25% compound annual growth rate …

kiplinger.com

23%
OFF

Moderna To Cut R&D Spending $1.1 B - STAT

3 weeks from now

Sep 12, 2024 · Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who …

statnews.com

$1
OFF

Moderna Plans $1.1B In R&D And Program Cuts, Delays Break-even …

3 weeks from now

Sep 12, 2024 · Stéphane Bancel has relented to Wall Street’s desire for cost-cutting and reining in Moderna’s pipeline. To kick off its annual R&D day in New York, Moderna said Thursday that it ...

endpts.com

FAQs about Moderna’s spending cuts, pipeline shakeup leave doubts about a … Coupon?

Why did Moderna stock drop 20% this year?

In a recent note, Jefferies analyst Michael Yee said Moderna needed to cut as much as $1 billion in expenses “to regain any investor confidence or credibility on profitability.” Shares dropped by 7% in premarket trading in New York on Thursday. Through Wednesday’s close, Moderna’s shares have dropped about 20% this year. ...

Will Moderna cut its research & development spending by 23%?

By Matthew Herper and Jason Mast Moderna said Thursday it would cut its annual spending on research and development by 23%, or $1.1 billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate. ...

Are Moderna's R&D cuts a sign of financial discipline?

“We are still dealing with a market of uncertainty,” Moderna Chief Financial Officer Jamey Mock said in an interview. “We hope that will settle out this year but we have to brace ourselves just in case vaccination rates continue to go down.” Mock said the R&D cuts are a sign that the company “is exercising financial discipline.” ...

Will Moderna's 2025 forecast make investors lose confidence?

The 2025 forecast, on the heels of the 2024 guidance cut issued when Moderna reported second-quarter earnings, “is likely making investors lose confidence” and battering the stock, Evercore ISI analyst Cory Kasimov said in a research note Thursday. Some analysts also questioned Moderna’s new timeline for breaking even. ...

How many new product approvals does Moderna expect in 2027?

The biotech company said it expects 10 new product approvals through 2027. But Moderna is also deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others. Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. ...

Will Moderna break even by 2028?

The announcement was made ahead of a meeting being held by Moderna on Thursday to update investors on its research and development efforts. The company also said that it plans to break even by 2028, when it expects it will reach annual sales of $6 billion. ...